Medicines Healthcare products Regulatory Authority was considering restricting vaccine amid concerns over rare blood clots
The UK’s medicines regulatory body has said that no decision has been made on any regulatory action relating to the Oxford/AstraZeneca vaccine following reports it is considering restricting use of the vaccine in younger people.
Channel 4 News reported on Monday night that the Medicines and Healthcare products Regulatory Agency (MHRA) was considering the restrictions amid concerns about rare blood clots, and a decision could be made as early as Tuesday.
Related: Blood clot cases ‘could dent faith of young women in AstraZeneca’
